The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention

Published:2022 Issue:7 Volume:52 Page:544
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Park Jiesuck¹^ORCID,Han Jung-Kyu¹^ORCID,Kang Jeehoon¹^ORCID,Chae In-Ho²^ORCID,Lee Sung Yun³^ORCID,Choi Young Jin⁴^ORCID,Rhew Jay Young⁵^ORCID,Rha Seung-Woon⁶^ORCID,Shin Eun-Seok⁷^ORCID,Woo Seong-Ill⁸^ORCID,Lee Han Cheol⁹^ORCID,Chun Kook-Jin¹⁰^ORCID,Kim DooIl¹¹^ORCID,Jeong Jin-Ok¹²^ORCID,Bae Jang-Whan¹³^ORCID,Yang Han-Mo¹^ORCID,Park Kyung Woo¹^ORCID,Kang Hyun-Jae¹^ORCID,Koo Bon-Kwon¹^ORCID,Kim Hyo-Soo¹^ORCID

Affiliation:

1. Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

2. Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea.

3. Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.

4. Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea.

5. Department of Internal Medicine and Cardiovascular Center, Presbyterian Medical Center, Jeonju, Korea.

6. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

7. Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

8. Department of Internal Medicine, Inha University Hospital, Incheon, Korea.

9. Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.

10. Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.

11. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

12. Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.

13. Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.

Funder

Chong Kun Dang Inc.

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://e-kcj.org/pdf/10.4070/kcj.2021.0395

Reference29 articles.

1. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

2. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

3. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

4. Prognostic Impact of β-Blocker Dose After Acute Myocardial Infarction

5. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population;Cardiovascular Drugs and Therapy;2023-08-18

2. Role of β-Blockers in Chronic Coronary Artery Disease Management in the Percutaneous Coronary Intervention Era: Good Symptom Control or Something More?;Korean Circulation Journal;2022